IM Cannabis Corp. (CSE:IMCC)
Canada
· Delayed Price · Currency is CAD 2.150
+0.100 (4.88%)
Apr 25, 2025, 10:24 AM EDT
IM Cannabis Company Description
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.
It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands.
The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.
IM Cannabis Corp.
| Country | Canada |
| Founded | 2008 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 95 |
| CEO | Oren Shuster |
Contact Details
Address: Kibbutz Glil Yam Tel Aviv, British Columbia 4690500 Israel | |
| Website | imcannabis.com |
Stock Details
| Ticker Symbol | IMCC |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| ISIN Number | CA44969Q3070 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Eyal Fisher | Chief Executive Officer and GM of the IMC Holdings |
| Richard Balla | Chief Executive Officer of Adjupharm |
| Oren Shuster | Executive Chairman and Chief Executive Officer |
| Uri Birenberg | Chief Financial Officer |
| Advocate Michal Lebovitz Nissimov | General Counsel and Secretary |
| Anna Taranko | Director Investor and Public Relations |